Solid Tumors
A Phase 1/2 Multiple Expansion Cohort Trial of the SOS1 Inhibitor MRTX0902 in Patients with Advanced Solid Tumors Harboring Mutations in the KRAS-MAPK Pathway (0902-001)
- Details
ClinicalTrials.gov ID:
NCT05578092
Diagnosis Type:
NA
USOR Number:
- Address
,
P: